Shashank Krishnakumar

My first one was on the gross margin expansion that we have seen Q-o-Q. I think the sale of API this quarter was still higher. So just trying to understand what has driven the sharp GM expansion on a Q-o-Q basis. And I also wanted to try and understand ho w should we look at it -- look at gross margins going forward, given that input costs are sort of inching up, though the mix improvement will also sort of play out?

Got it. My second question on the capex plan for FY '27-'28. If you could just sort of highlight how you are looking at it in terms of the overall figure and -- as well as which are the areas where we should see the incremental investment being deployed, if you could just share that?

Any figure which you could sort of share?

Yes. Hi, thanks for taking my question. So , my first one was on the six late stage assets. I think in the last call we did indicate that we have seen some RFPs for one phase-III and two commercialized products. So anything incremental in terms of updates that you might have to share, whether we can see some of these getting converted into orders say sometime next year, FY28, any update there?

Thank you. That is helpful. And the second one on the new sweetener that we are looking to commercialize. Can we sort of expect it to start contributing meaningfully from FY27 or will this largely be contingent on the Vizag capacity coming in and then we will probably start seeing this contributing to the sweetener revenue, how should we think about it?

Got it, sir. Thanks. That is it from my side.